Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Endocrinol (Oxf) ; 70(2): 252-8, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18547339

RESUMO

OBJECTIVE: Pseudohypoaldosteronism type I (PHA1) is a rare inborn disease causing severe salt loss. Mutations in the three coding genes of the epithelial sodium channel (ENaC) are responsible for the systemic autosomal recessive form. So far, no phenotype has been reported in heterozygous carriers. PATIENTS: A consanguineous family from Somalia giving birth to a neonate suffering from PHA1 was studied including clinical and hormonal characteristics of the family, mutational analysis of the SCNN1A, SCNN1B, SCNN1G and CFTR genes and in vitro analysis of the functional consequences of a mutant ENaC channel. RESULTS: CFTR mutations have been excluded. SCNN1A gene analysis revealed a novel homozygous c.1684T > C mutation resulting in a S562P substitution in the alphaENaC protein of the patient. Functional analysis showed a significantly reduced S562P channel function compared to ENaC wild type. Protein synthesis and channel subunit assembly were not altered by the S562P mutation. Co-expression of mutant and wild-type channels revealed a dominant negative effect. In heterozygote carriers, sweat sodium and chloride concentrations were increased without additional hormonal or clinical phenotypes. CONCLUSION: Hence, the novel mutation S562P is causing systemic PHA1 in the homozygous state. A thorough clinical investigation of the heterozygote SCNN1A mutation carriers revealed increased sweat sodium and chloride levels consistent with a dominant effect of the mutant S562P allele. Whether this subclinical phenotype is of any consequence for the otherwise asymptomatic heterozygous carriers has to be elucidated.


Assuntos
Canais Epiteliais de Sódio/genética , Heterozigoto , Mutação de Sentido Incorreto/genética , Fenótipo , Pseudo-Hipoaldosteronismo/genética , Alelos , Cloretos/metabolismo , Feminino , Humanos , Recém-Nascido , Linhagem , Pseudo-Hipoaldosteronismo/metabolismo , Sódio/metabolismo , Suor/metabolismo
2.
Autophagy ; 2(2): 140-2, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16874064

RESUMO

Despite abundant evidence for autophagic cell death as a morphological type, the notion that autophagy can actually contribute mechanistically to the cell's death is controversial. In cells capable of apoptosis, autophagic cell death has been dismissed by some authors as a morphologically unusual form of apoptosis. But strong recent evidence for autophagy-mediated death of cells rendered incapable of apoptosis has been criticized on the grounds that this cell death is too artificial to be relevant to normal cells. We here argue from our own and other recent evidence that autophagy can mediate the death even of apoptosis-competent cells.


Assuntos
Apoptose/fisiologia , Autofagia/fisiologia , Adenina/análogos & derivados , Adenina/farmacologia , Androstadienos/farmacologia , Animais , Apoptose/efeitos dos fármacos , Autofagia/efeitos dos fármacos , Cromonas/farmacologia , Células HeLa , Humanos , Morfolinas/farmacologia , Células PC12 , Fosfatidilinositol 3-Quinases/metabolismo , Inibidores de Fosfoinositídeo-3 Quinase , Ratos , Transdução de Sinais , Wortmanina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA